3.8 Proceedings Paper

Increasing the Accuracy of Optipharm's Virtual Screening Predictions by Implementing Molecular Flexibility

Journal

Publisher

SPRINGER INTERNATIONAL PUBLISHING AG
DOI: 10.1007/978-3-031-07802-6_20

Keywords

Ligand based virtual screening; Molecule's flexibility; Optimization

Funding

  1. Spanish Ministry of Economy and Competitiveness [CTQ2017-87974-R, RTI2018-095993-B-I00, EQC2019-006418-P]
  2. Junta de Andalucia [P18-RT-1193]
  3. Programa Regional de Fomento de la Investigacion (Plan de Actuacion 2018, Region de Murcia, Spain) [20988/PI/18]
  4. University of Almeria [UAL18-TIC-A020-B]
  5. European Union (NextGenerationEU) [RR A 2021 21]

Ask authors/readers for more resources

OptiPharm is a new software that optimizes the similarity of molecules and competes well with other algorithms. However, all methods, including OptiPharm, assuming proteins as rigid can lead to inaccurate predictions. This study extends OptiPharm's functionality by considering molecular flexibility, introducing improvements that enhance prediction accuracy.
Recently, a new piece of software called OptiPharm has been proposed to optimize the similarity between two given molecules. A comprehensive study proved it was very competitive compared with state-of-the-art algorithms such as WEGA and ROCS. However, all of these methods, including OptiPharm, assume the proteins as rigid, resulting in poor or inefficient predictions. The consideration of conformational changes and thus the molecule's flexibility is necessary. In this work, we have extended the OptiPharm's functionality by applying a methodology that considers the flexibility of the molecules. Apart from that, the new OptiPharm presents some strengths regarding its previous version. More precisely, it reduces the search space dimension and introduces circular limits for the angular variables to enhance searchability. As results will show, these improvements help OptiPharm to achieve better predictions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available